CCTV News: On January 24, the Data Management Office of the Drug Review Center of the State Food and Drug Administration issued a correction note. Recently, the center has received reports from relevant media and enterprises that there are duplication of data in individual varieties disclosed to the website of the National Medical Products Administration’s Drug Review Center.
The center attached great importance to it and immediately verified the data of relevant varieties. After verification, the above problems were caused by editing errors when the relevant product information was disclosed in 2019 and 2021. The center has corrected the error message on the center website as soon as possible.
The center apologizes for the mistakes that occurred in work. In the future, the center will strengthen the review of public information to avoid similar problems from happening again. Supervision from all walks of life is welcome!
